Explore
Advances and Novel Treatment Options in Metastatic Melanoma
0 Ungluers have
Faved this Work
Login to Fave
The book presents several studies reporting advances on melanoma pathogenesis, diagnosis and therapy. It represents a milestone on the state of the art, updated at 2021, and also presents the current knowledge on the future developments in melanoma field.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 40 times via unglue.it ebook links.
- 40 - pdf (CC BY) at Unglue.it.
Keywords
- ABT-737
- acetazolamide
- Acetylcholine
- adjuvant therapy
- amoeboid motility
- Angiogenesis
- Apoptosis
- arthralgia
- Bcl-2 family
- BCL2L10
- biomarkers
- BRAF
- BRAF inhibitor
- BRAF inhibitors
- BRAF-mutant melanoma
- Cancer
- cancer associated fibroblast
- cancer stem cells
- carbonic anhydrase
- cell therapy
- checkpoint inhibitor
- cholinergic system
- combined therapy
- ctDNA
- CXCL10
- cyclopamine
- Cytokines
- Cytotoxicity
- Diagnosis
- DOCK4
- drug resistance
- essential oils
- Exosomes
- extracellular vesicles
- FAK
- hedgehog
- Hippo
- HuR
- Immunity
- Immunotherapy
- interferon
- Invasion
- ipilimumab
- Lactate dehydrogenase
- Lipid Metabolism
- Liquid Biopsy
- liver-directed-therapies
- Machine learning
- MANS peptide
- MARCKS
- mechanism of action
- medicine
- Melanoma
- melanoma immune infiltrate
- melanoma markers
- melanoma metastasis
- melanoma PDX
- melanomagenesis
- metalloproteinases
- metastases
- metastasis
- metastatic dormancy
- metastatic therapy
- metastatic uveal melanoma (mUM)
- microenvironment
- MicroRNAs
- MITF
- ML258
- motility
- mucosal melanoma
- muscarinic receptors
- n/a
- Nanoparticles
- nicotinic receptors
- Nivolumab
- OXPHOS
- patient stratification
- PD-1
- pembrolizumab
- Phosphorylation
- plasmacytoid dendritic cells
- prediction
- principal component analysis
- prognosis
- prognostication
- protein tyrosine phosphatase
- PTPs inhibitors
- Rac1
- Radiotherapy
- Resistance
- Rheumatoid arthritis
- sex-hormones
- sex/gender
- ShcD adaptor protein
- siRNA
- slow cycling phenotype
- small molecules
- SOCE
- STAT3
- support vector machine
- Survival
- target therapy
- targeted therapy
- targeted-therapy
- therapeutic resistance
- Therapy
- TLR
- TPC2
- Tumor microenvironment
- tumour microenvironment
- uveal melanoma (UM)
- WNT5A
Links
DOI: 10.3390/books978-3-0365-3303-2Editions